Literature DB >> 7842220

Tussive effect of capsaicin in patients with gastroesophageal reflux without cough.

M Ferrari1, M Olivieri, C Sembenini, L Benini, V Zuccali, E Bardelli, P Bovo, G Cavallini, I Vantini, V Lo Cascio.   

Abstract

The aim of this study was to clarify the influence of gastroesophageal reflux (GER) on cough threshold in patients with digestive symptoms but free from respiratory involvement. Of 57 consecutive subjects referred for 24-h esophageal pH monitoring because of digestive reflux symptoms, 29 patients free from respiratory disorders were studied. They underwent esophageal pH monitoring and manometry, upper gastrointestinal endoscopy, pulmonary function tests, and methacholine and capsaicin challenges. The methacholine test was performed by inhalation of increasing doses of methacholine up to 4,000 micrograms; the results were expressed as the dose causing a 20% decrease in FEV1 from baseline (PD20). The capsaicin threshold was evaluated by inhalation of increasing doses of capsaicin from 0.3 up to 9.84 nmol, expressing the results as the dose of capsaicin eliciting five coughs (PD5). Fifteen patients were considered refluxers on the basis of a total esophageal acid exposure time above 4.7%. Esophagitis grade 0 was found in 15 patients, grade 1 in seven patients, grade 2 in seven patients. PD5 was significantly lower in refluxers (median 0.51 micrograms, range 0.22 to 19.8) than in nonrefluxers (19.8 micrograms, range 0.31 to 19.8) (p < 0.001); there was no difference in baseline ventilatory parameters and in airway responsiveness to methacholine between the two groups. All patients with a pathologic acid exposure time but one had a low cough threshold, irrespective of the presence or absence of esophagitis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7842220     DOI: 10.1164/ajrccm.151.2.7842220

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  14 in total

Review 1.  Cough challenge in the assessment of cough reflex.

Authors:  A H Morice; J A Kastelik; R Thompson
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

Review 2.  Cough . 6: Which investigations are most useful in the diagnosis of chronic cough?

Authors:  L P A McGarvey
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

3.  Does laparoscopic fundoplication provide long-term control of gastroesophageal reflux related cough?

Authors:  C J Allen; M Anvari
Journal:  Surg Endosc       Date:  2004-03-19       Impact factor: 4.584

4.  Recommendations for the management of cough in adults.

Authors:  A H Morice; L McGarvey; I Pavord
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

5.  Reflux associated cough is usually not associated with reflux: role of reduced cough threshold.

Authors:  L Benini; M Ferrari; G Talamini; I Vantini
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

6.  Cough threshold in reflux oesophagitis: influence of acid and of laryngeal and oesophageal damage.

Authors:  L Benini; M Ferrari; C Sembenini; M Olivieri; R Micciolo; V Zuccali; G M Bulighin; F Fiorino; A Ederle; V L Cascio; I Vantini
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

7.  Relevance of GERD in lung transplant patients.

Authors:  Veerle Mertens; Lieven Dupont; Daniel Sifrim
Journal:  Curr Gastroenterol Rep       Date:  2010-06

Review 8.  Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.

Authors:  Anne B Chang; Toby J Lasserson; Justin Gaffney; Frances L Connor; Luke A Garske
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

Review 9.  Cough and gastroesophageal reflux: insights from animal models.

Authors:  Marian Kollarik; Mariana Brozmanova
Journal:  Pulm Pharmacol Ther       Date:  2008-12-31       Impact factor: 3.410

10.  A randomised, placebo controlled trial of inhaled salbutamol and beclomethasone for recurrent cough.

Authors:  A B Chang; P D Phelan; J B Carlin; S M Sawyer; C F Robertson
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.